This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Peden, A. H. Articles by Ironside, J. W. Search for Related Content PubMed PubMed Citation Articles by Peden, A. H. Articles by Ironside, J. W.

(American Journal of Pathology. 2006;168:927-935.)
© 2006 American Society for Investigative Pathology

Detection and Localization of PrP^Sc in the Skeletal Muscle of Patients with Variant, Iatrogenic, and Sporadic Forms of Creutzfeldt-Jakob Disease

From the National Creutzfeldt-Jakob Disease Surveillance Unit and Division of Pathology, School of Molecular and Clinical Medicine, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom

Variant Creutzfeldt-Jakob disease (vCJD) differs from other human prion diseases in that the pathogenic prion protein PrP^Sc can be detected to a greater extent at extraneuronal sites throughout the body, principally within lymphoid tissues. However, a recent study using a high-sensitivity Western blotting technique revealed low levels of PrP^Sc in skeletal muscle from a quarter of Swiss patients with sporadic CJD (sCJD). This posed the question of whether PrP^Sc in muscle could also be detected in vCJD, sCJD, and iatrogenic (iCJD) patients from other populations. Therefore, we have used the same high-sensitivity Western blotting technique, in combination with paraffin-embedded tissue blotting, to screen for PrP^Sc in muscle tissue specimens taken at autopsy from 49 CJD patients in the United Kingdom. These techniques identified muscle PrP^Sc in 8 of 17 vCJD, 7 of 26 sCJD, and 2 of 5 iCJD patients. Paraffin-embedded tissue blotting analysis showed PrP^Sc in skeletal muscle in localized anatomical structures that had the morphological and immunohistochemical characteristics of nerve fibers. The detection of PrP^Sc in muscle tissue from all forms of CJD indicates the possible presence of infectivity in these tissues, suggesting important implications for assessing the potential risk of iatrogenic spread via contaminated surgical instruments.

This article has been cited by other articles:

				P. Brown Transmissible spongiform encephalopathy in the 21st century: Neuroscience for the clinical neurologist Neurology, February 26, 2008; 70(9): 713 - 722. [Full Text] [PDF]

				V. A. Lawson, J. D. Stewart, and C. L. Masters Enzymatic detergent treatment protocol that reduces protease-resistant prion protein load and infectivity from surgical-steel monofilaments contaminated with a human-derived prion strain J. Gen. Virol., October 1, 2007; 88(10): 2905 - 2914. [Abstract] [Full Text] [PDF]

				I. P. Lipscomb, R. Herve, K. Harris, H. Pinchin, R. Collin, and C. W. Keevil Amyloid-specific fluorophores for the rapid, sensitive in situ detection of prion contamination on surgical instruments J. Gen. Virol., September 1, 2007; 88(9): 2619 - 2626. [Abstract] [Full Text] [PDF]

				W. M. Dlakic, E. Grigg, and R. A. Bessen Prion Infection of Muscle Cells In Vitro J. Virol., May 1, 2007; 81(9): 4615 - 4624. [Abstract] [Full Text] [PDF]